A functional assay for heparin in serum using a designed synthetic receptor

Angewandte Chemie - International Edition

Volumn 44, Issue 35, 2005, Pages 5679-5682

  Wright, Aaron T ^a   Zhong, Zhenlin ^a   Anslyn, Eric V ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Fluorescence; Heparin; Host guest systems; Receptors; Supramolecular chemistry

Indexed keywords

AMMONIUM COMPOUNDS; CARBOXYLIC ACIDS; COAGULATION; DOSIMETRY; FLUORESCENCE; QUENCHING; SUPRAMOLECULAR CHEMISTRY;

HEPARIN; HOST-GUEST SYSTEMS; RECEPTORS; SERUM;

POLYSACCHARIDES;

CELL SURFACE RECEPTOR; HEPARIN; HEPARIN RECEPTOR; LOW MOLECULAR WEIGHT HEPARIN;

ANIMAL; ARTICLE; BLOOD; CALIBRATION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG MONITORING; HORSE; HUMAN; METHODOLOGY; STANDARD;

ANIMALS; CALIBRATION; DRUG MONITORING; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HORSES; HUMANS; MOLECULAR STRUCTURE; RECEPTORS, CELL SURFACE; REFERENCE STANDARDS;

EID: 24944552144     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200501437     Document Type: Article

References (33)

1. a) S. L. Tobey, E. V. Anslyn, Org. Lett. 2003, 5, 2029-2031;
2. b) Z. Zhong, E. V. Anslyn, Angew. Chem. 2003, 115, 3113-3116;
3. Angew. Chem. Int. Ed. 2003, 42, 3005-3008.
4. G. J. Despotis, G. Gravlee, K. Filos, J. Levy, Anesthesiology 1999, 91, 1122-1151.
5. J. Hirsh, J. E. Dalen, D. Deykin, L. Poller, Chest 1992, 102, 337S-352S.
6. a) T.-J. Cheng, T.-M. Lin, T.-H. Wu, H.-C. Chang, Anal. Chim. Acta. 2001, 432, 101-111;
7. b) J. M. Thomson, L. Poller in Blood Coagulation and Haemostasis (Ed.: J. M. Thomson), Churchill Livingstone, Edinburgh, Scotland, 1989, pp. 301-339;
8. c) S.-C. Ma, V. C. Yang, M. E. Meyerhoff, Anal. Chem. 1992, 64, 694-697;
9. d) V. C. Yang, W.-C. Ma, B. Fu, M. E. Meyerhoff, Anal. Chem. 1993, 65, 2078-2084;
10. e) N. Ramamurthy, N. Baliga, J. A. Wahr, U. Schaller, V. C. Yang, M. E. Meyerhoff, Clin. Chem. 1998, 44, 606-613;
11. f) N. Ramamurthy, N. Baliga, T. W. Wakefield, P. C. Andrews, V. C. Yang, M. E. Meyerhoff, Anal. Biochem. 1999, 266, 116-124;
12. g) S. Mathison, E. Bakker, Anal. Chem. 1999, 71, 4614-4621;
13. h) G. A. Mitchell, R. J. Gargiulo, R. M. Huseby, D. E. Lawson, S. P. Pochron, J. A. Sehuanes, Thromb. Res. 1978, 13, 47-52;
14. i) E. Homer, Thromb. Haemost. 1985, 54, 29-31.
15. a) R. J. Linhardt, T. Toida in Carbohydrates in Drug Design (Eds.: Z. J. Witczak, K. A. Nieforth), Marcel Dekker, New York, New York, 1997, pp. 277-341;
16. b) L. Poller, J. M. Thomson, K. F. Yee, Br. J. Haematol. 1980, 44, 161-165;
17. c) S. Kitchen, Br. J. Haematol. 2000, 111, 397-406.
18. S. Cai, J. L. Dufner-Beattie, G. D. Prestwich, Anal. Biochem. 2004, 326, 33-41.
19. a) J. I. Weitz, N. Engl. J. Med. 1997, 337, 688-698;
20. b) I. Bjork, U. Lindahl, Mol. Cell. Biochem. 1982, 48, 161;
21. c) R. Jordan, D. Beeler, R. Rosenberg, J. Biol. Chem. 1979, 254, 2902-2913.
22. R. H. Lorentsen, J. H. Graversen, N. R. Caterer, H. C. Thøgersen, M. Etzerodt, Biochem. J. 2000, 347, 83-87.
23. Z. Zhong, E. V. Anslyn, J. Am. Chem. Soc. 2002, 124, 9014-9015.
24. S. L. Wiskur, J. J. Lavigne, H. Ait-Haddou, V. Lynch, Y. H. Chiu, J. W. Canary, E. V. Anslyn, Org. Lett. 2001, 3, 1311-1314.
25. a) S. L. Wiskur, J. J. Lavigne, A. Metzger, S. L. Tobey, V. Lynch, E. V. Anslyn, Chem. Eur. J. 2004, 10, 3792-3804;
26. b) K. Burgess, A. M. Porte, Angew. Chem. 1994, 106, 1218-1220;
27. Angew. Chem. Int. Ed. Engl. 1994, 33, 1182-1184;
28. c) J. J. Lavigne, E. V. Anslyn, Angew. Chem. 1999, 111, 3903-3906;
29. Angew. Chem. Int. Ed. 1999, 38, 3666-3669.
30. S. L. Wiskur, H. Ait-Haddou, E. V. Anslyn, J. J. Lavigne, Acc. Chem. Res. 2001, 34, 963-972.
31. a) S. A. McFarland, N. S. Finney, J. Am. Chem. Soc. 2001, 123, 1260-1261;
32. b) J. V. Mello, N. S. Finney, Angew. Chem. 2001, 113, 1584-1586;
33. Angew. Chem. Int. Ed. 2001, 40, 1536-1538.